Advertisement

The Essentials in Hemodialysis

  • Paul Jungers
  • Johanna Zingraff
  • Nguyen K. Man
  • Tilman Drueke

Part of the The Tardieu Series book series (TARD, volume 1)

Table of contents

  1. Front Matter
    Pages 1-8
  2. Paul Jungers, Johanna Zingraff, Nguyen K. Man, Tilman Drueke
    Pages 9-9
  3. Paul Jungers, Johanna Zingraff, Nguyen K. Man, Tilman Drueke
    Pages 11-12
  4. Paul Jungers, Johanna Zingraff, Nguyen K. Man, Tilman Drueke
    Pages 13-18
  5. Paul Jungers, Johanna Zingraff, Nguyen K. Man, Tilman Drueke
    Pages 19-27
  6. Paul Jungers, Johanna Zingraff, Nguyen K. Man, Tilman Drueke
    Pages 28-35
  7. Paul Jungers, Johanna Zingraff, Nguyen K. Man, Tilman Drueke
    Pages 36-39
  8. Paul Jungers, Johanna Zingraff, Nguyen K. Man, Tilman Drueke
    Pages 40-47
  9. Paul Jungers, Johanna Zingraff, Nguyen K. Man, Tilman Drueke
    Pages 48-69
  10. Paul Jungers, Johanna Zingraff, Nguyen K. Man, Tilman Drueke
    Pages 70-86
  11. Paul Jungers, Johanna Zingraff, Nguyen K. Man, Tilman Drueke
    Pages 87-89
  12. Back Matter
    Pages 90-102

About this book

Introduction

At the end of 1976 there were 34,215 people with end-stage renal disease alive on dialysis and transplantation within the registry centers of the European Dialysis and Transplant Association (14:4, 1977). From July, 1973, when the American Government began to fund dialysis, the estimated number of dialysis patients in the United States has risen from 5,000 plus to over 35,000. Jfwe add other regions, such as Canada, Australasia and Latin America, it is safe to say that as this is written, over 100,000 people are living on dialysis. The u.s. Social Security System, Veterans Administration, Medicaid and State Agencies are now paying out over one billion dollars annually to support patients on dialysis in the U. S.A. Cobe, Redy, Travenol, Dow Cordis, Drake Willock, Gambro, Asahi, Erica and a host of other company names have become household words in many households throughout the world. I cite these factors not out of a pretense at precision or a passion for phenomenology, but simply to indicate that dialysis has become lore than this century's therapeutic miracle. (Perhaps the first treatable fatal chronic, terminal, medical disease I). It has also become big business! As such, it has perhaps become too important to be left solely in the hands of medical specialists, such as nephrologists.

Keywords

child dialysis diseases fat hemodialysis kidney lead metabolism monitoring organizations quality quality of life toxicity transplantation water

Authors and affiliations

  • Paul Jungers
    • 1
  • Johanna Zingraff
    • 2
  • Nguyen K. Man
    • 2
  • Tilman Drueke
    • 3
  1. 1.Faculty of Medicine Necker-Enfants MaladesNecker HospitalParisFrance
  2. 2.INSERM U 25Necker HospitalParisFrance
  3. 3.Faculty of Medicine NeckerNecker HospitalParisFrance

Bibliographic information

  • DOI https://doi.org/10.1007/978-94-009-9738-7
  • Copyright Information Springer Science+Business Media B.V. 1978
  • Publisher Name Springer, Dordrecht
  • eBook Packages Springer Book Archive
  • Print ISBN 978-90-247-2103-0
  • Online ISBN 978-94-009-9738-7
  • Buy this book on publisher's site